This was the first head-to-head comparison, published in the New England Journal of Medicine
Metformin also appears to reduce appetite in some individuals, possibly through effects on gut hormones including glucagon-like peptide-1 (GLP-1), though this mechanism remains incompletely understood
Lindner A., Marienhospital Stuttgart, Department of Neurology
10.1111/j.1365-313X.2012.05105.x 16 IqbalN.UmarS.KhanN
3.3.4 Polyethylene glycol loxenatide The early GLP-1R agonist has many defects, such as multiple injections and a high incidence of adverse reactions in the digestive tract, which limits its clinical application
Future Regulatory Outlook: If ongoing Phase 23 trials in men demonstrate clear safety and efficacy, we could see an FDA submission for a male indication (for ED or another male sexual disorder) in a couple of years